It appears you have not yet Signed Up with our community. To Sign Up for free, please click here....



Hepatitis Message Board


Hepatitis Board Index
Board Index > Hepatitis | 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


[QUOTE=Charmed.1;2947459]What gen are you? Are you taking a multi-vitamin or anything?[/QUOTE]

Hi Charmed, Hope all is going good for you today. I am a geo 1 and stage 1. I don't know what a gen means. I'm not one for taking meds or vitamins. I never have been. All I take for now is what I am given for my treatment and Aleive, and dramamine. I am in good health except for this HepC.

The new experimental drug called SCH 503034 along with standard therapy get a better response rate and possibly in a shorter amount of time. There are different types of Hepatitis C virus (HCV). The most common kinds are called the genotypes 1 through 6. This study will enroll only patients with HCV genotype 1 who have not previously received treatment.

Pegylated interferon (such as Pegintron) and Ribavirin (such as Revetol) are the current standard treatments for patients with chronic hepatitis C. However, only around 50 percent of patients with HCV genotype 1 will respond to standard therapy. The purpose of this study is to see if patients infected with HCV genotype 1 who receive a new experimental drug called SCH 503034, is a protease inhibitor which works differently than PegIntron and Rebetol. SCH 503034 interferes with the ability of the hepatitis C virus to release new active virus particles into the bloodstream.

This study will compare the response rate of SCH 503034 taken with PegIntron and Rebetol for 28 or 48 weeks to the current standard treatment which is PegIntron with Rebetol for 48 weeks.

This study will see if the response rate is better if PegIntron and Rebetol are given for 4 weeks followed by 24 or 44 weeks of PegIntron, Rebetol and SCH 503034.

This study will compare the safety of SCH 503034 taaken with PigIntron and Rebetol to the safety of a standard treatment (PegIntron and Rebetol).

I hope you can understand what I copied from my paper work about the SCH 503034. This study is currently recruiting patients.. verified by Shering-Plough April 2007. Any one can go to ClinicalTrials.gov if you would like any more information on trails being done in your state. Blu
[QUOTE=MistyBlu211;2951228]Hi Charmed, Hope all is going good for you today. I am a geo 1 and stage 1. I don't know what a gen means. I'm not one for taking meds or vitamins. I never have been. All I take for now is what I am given for my treatment and Aleive, and dramamine. I am in good health except for this HepC.

The new experimental drug called SCH 503034 along with standard therapy get a better response rate and possibly in a shorter amount of time. There are different types of Hepatitis C virus (HCV). The most common kinds are called the genotypes 1 through 6. This study will enroll only patients with HCV genotype 1 who have not previously received treatment.

Pegylated interferon (such as Pegintron) and Ribavirin (such as Revetol) are the current standard treatments for patients with chronic hepatitis C. However, only around 50 percent of patients with HCV genotype 1 will respond to standard therapy. The purpose of this study is to see if patients infected with HCV genotype 1 who receive a new experimental drug called SCH 503034, is a protease inhibitor which works differently than PegIntron and Rebetol. SCH 503034 interferes with the ability of the hepatitis C virus to release new active virus particles into the bloodstream.

This study will compare the response rate of SCH 503034 taken with PegIntron and Rebetol for 28 or 48 weeks to the current standard treatment which is PegIntron with Rebetol for 48 weeks.

This study will see if the response rate is better if PegIntron and Rebetol are given for 4 weeks followed by 24 or 44 weeks of PegIntron, Rebetol and SCH 503034.

This study will compare the safety of SCH 503034 taaken with PigIntron and Rebetol to the safety of a standard treatment (PegIntron and Rebetol).

I hope you can understand what I copied from my paper work about the SCH 503034. This study is currently recruiting patients.. verified by Shering-Plough April 2007. Any one can go to ClinicalTrials.gov if you would like any more information on trails being done in your state. Blu[/QUOTE]

Gen type is like the strain you have. There are I think six but only the first three are found here in the us. Good luck with everything. That is interesting the new treatments.





All times are GMT -7. The time now is 10:24 PM.





© 2022 MH Sub I, LLC dba Internet Brands. All rights reserved.
Do not copy or redistribute in any form!